MIB2
Basic information
Region (hg38): 1:1615454-1630605
Previous symbols: [ "ZZANK1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MIB2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 15 | |||||
missense | 80 | 87 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 12 | 16 | ||||
Total | 0 | 0 | 92 | 18 | 8 |
Variants in MIB2
This is a list of pathogenic ClinVar variants found in the MIB2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-1615464-C-CG | Benign (Dec 31, 2019) | |||
1-1615470-C-A | not specified | Uncertain significance (May 12, 2024) | ||
1-1615497-C-A | not specified | Uncertain significance (Apr 04, 2023) | ||
1-1615511-C-T | not specified | Uncertain significance (Feb 28, 2023) | ||
1-1615512-C-T | not specified | Uncertain significance (Mar 01, 2024) | ||
1-1615514-A-G | not specified | Uncertain significance (Dec 20, 2022) | ||
1-1615584-G-C | not specified | Uncertain significance (Jan 10, 2022) | ||
1-1615602-T-C | not specified | Uncertain significance (Aug 01, 2022) | ||
1-1615612-C-A | not specified | Likely benign (Dec 31, 2019) | ||
1-1616568-C-G | Benign (Jun 29, 2018) | |||
1-1616568-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
1-1616569-C-T | not specified | Uncertain significance (Jul 13, 2022) | ||
1-1616577-C-T | not specified | Uncertain significance (Sep 20, 2023) | ||
1-1616601-G-C | not specified | Uncertain significance (Feb 12, 2024) | ||
1-1616607-C-G | not specified | Uncertain significance (Mar 01, 2023) | ||
1-1623402-C-T | not specified | Uncertain significance (Oct 18, 2021) | ||
1-1623438-G-A | not specified | Uncertain significance (Mar 23, 2023) | ||
1-1623445-C-T | not specified | Likely benign (Mar 07, 2024) | ||
1-1623546-G-A | not specified | Uncertain significance (May 27, 2022) | ||
1-1623567-C-G | not specified | Uncertain significance (Sep 12, 2023) | ||
1-1623600-C-T | not specified | Uncertain significance (Dec 06, 2022) | ||
1-1623616-A-C | not specified | Uncertain significance (May 25, 2022) | ||
1-1623626-G-C | not specified | Likely benign (Apr 07, 2023) | ||
1-1623633-C-T | not specified | Uncertain significance (Mar 04, 2024) | ||
1-1623645-C-T | not specified | Uncertain significance (Sep 17, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MIB2 | protein_coding | protein_coding | ENST00000505820 | 20 | 15196 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.80e-7 | 1.00 | 124036 | 7 | 574 | 124617 | 0.00233 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.623 | 644 | 690 | 0.933 | 0.0000494 | 6664 |
Missense in Polyphen | 196 | 269.45 | 0.72741 | 2660 | ||
Synonymous | -3.36 | 395 | 319 | 1.24 | 0.0000251 | 2280 |
Loss of Function | 3.59 | 19 | 45.0 | 0.422 | 0.00000237 | 476 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0315 | 0.0300 |
Ashkenazi Jewish | 0.0000998 | 0.0000995 |
East Asian | 0.000420 | 0.000390 |
Finnish | 0.00173 | 0.00153 |
European (Non-Finnish) | 0.000329 | 0.000283 |
Middle Eastern | 0.000420 | 0.000390 |
South Asian | 0.000408 | 0.000392 |
Other | 0.000875 | 0.000825 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination of Delta receptors, which act as ligands of Notch proteins. Positively regulates the Delta-mediated Notch signaling by ubiquitinating the intracellular domain of Delta, leading to endocytosis of Delta receptors. {ECO:0000250|UniProtKB:Q8R516}.;
- Pathway
- NOTCH-Ncore;Disease;Signal Transduction;Immune System;Adaptive Immune System;Signaling by NOTCH1;Antigen processing: Ubiquitination & Proteasome degradation;Signaling by NOTCH2;NOTCH3 Activation and Transmission of Signal to the Nucleus;Class I MHC mediated antigen processing & presentation;Signaling by NOTCH3;Signaling by NOTCH;NOTCH2 Activation and Transmission of Signal to the Nucleus;Constitutive Signaling by NOTCH1 HD Domain Mutants;Signaling by NOTCH1 HD Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Diseases of signal transduction;Activated NOTCH1 Transmits Signal to the Nucleus
(Consensus)
Recessive Scores
- pRec
- 0.129
Intolerance Scores
- loftool
- 0.153
- rvis_EVS
- -0.03
- rvis_percentile_EVS
- 50.56
Haploinsufficiency Scores
- pHI
- 0.176
- hipred
- Y
- hipred_score
- 0.639
- ghis
- 0.578
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.991
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mib2
- Phenotype
- homeostasis/metabolism phenotype; growth/size/body region phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein polyubiquitination;Notch signaling pathway;protein ubiquitination;positive regulation of I-kappaB kinase/NF-kappaB signaling
- Cellular component
- ubiquitin ligase complex;cytoplasm;early endosome;cytosol
- Molecular function
- actin binding;ubiquitin-protein transferase activity;protein binding;zinc ion binding;ubiquitin protein ligase activity